Guides
Research guides
New to peptides? Start with the basics. Reading a study? Learn what its design and results can tell you, and what they leave unanswered.
Follow a learning path
Start with five short reads, keep track of your progress, and return whenever you are ready.
What are peptides?
A plain-English primer on peptide basics and why context matters.
Peptide safety
Understand known risks, gaps in safety data, and why product identity matters.
Clinical trials explained
How to read trial phases, endpoints, registries, and early results.
FDA-approved peptide medicines
A guide to product-specific approval rather than broad class claims.
Peptide research glossary
Plain-English definitions for approval, trial, receptor, and safety terms.
Research updates
Elamipretide confirmatory trial appears after accelerated approval
Why the 4TAZPower trial matters for Forzinity's narrow Barth syndrome approval.
FDA approves tirzepatide for obstructive sleep apnea in adults with obesity
What the Zepbound approval covers, what supported it, and what it does not mean.
Retatrutide Phase 3 program reports top-line results
What company-reported Phase 3 results do and do not mean while retatrutide remains investigational.